Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives

Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives

Lori M Minasian,1 Ann O’Mara,2,3 Sandra A Mitchell4 1Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA; 2Consultant, ICF, Fairfax, VA, USA; 3Consultant to Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA; 4Division of Cancer Control and Population...

Full description

Bibliographic Details
Main Authors: Minasian LM, O'Mara A, Mitchell SA
Format: Article
Language:English
Published: Dove Medical Press 2022-12-01
Series:Patient Related Outcome Measures
Subjects:
patient-reported outcomes version of the common terminology criteria for adverse events
pro-ctcae
patient-reported outcomes
cancer therapy
toxicity
tolerability
Online Access:https://www.dovepress.com/clinician-and-patient-reporting-of-symptomatic-adverse-events-in-cance-peer-reviewed-fulltext-article-PROM

Internet

https://www.dovepress.com/clinician-and-patient-reporting-of-symptomatic-adverse-events-in-cance-peer-reviewed-fulltext-article-PROM

Similar Items